Back to All Events

Are Hybrid Trials the Answer to Aligning Decentralized Methods with Diversity Goals?

This interactive presentation provides an in-depth look at, and tools and resources for, protocol development with the goal of aligning the principles set forth in the U.S. Food and Drug Administration's draft guidance on diversity, equity, and inclusion (DEI) with the application of methods for decentralized clinical trials (DCTs) in the field.

CEU: 2.00 ACRP

Speaker:

Nadina Jose, MD, Assistant Professor, School of Health Professions, Rutgers, The State University of New Jersey